Skip to content
MomMetabolicEVIDENCE-FIRST METABOLIC HEALTH
Menu
Grade C

AHBARx review

Written by Elena Voss, Metabolic Health Editor

Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Prices and terms come from the company's own published pages. This is background reading, not medical advice.

Everything about the price is public and nothing about the company is. AHBARx publishes six figures before you enter anything: compounded semaglutide at $249 a month, $649 for three months and $1,199 for six, and tirzepatide at $349, $949 and $1,799, which works out to about $200 and $300 a month on the longest plan. The advertised savings are exact to the dollar against its own monthly rate, which is rarer than it should be. The problem sits in the legal documents. No operating entity is named anywhere on the public site, and the terms and privacy policy are an unfilled template in which the compounding pharmacies, the laboratories and the medical groups are all literal bracketed placeholders — as is the site's own web address. It sells NAD+, sermorelin and glutathione alongside the GLP-1s, claims all fifty states without listing them, and says nothing about pregnancy, breastfeeding or postpartum timing.

$249/mo
Consult Medication
See plans at AHBARx
  • Confirm HSA / FSA coverage
  • Public information reviewed
  • Confirm your total cost
Compare alternatives ↓

AHBARx at a glance

Semaglutide
$249/mo
Tirzepatide
$349/mo
Coverage
All 50 states, claimed but not enumerated
Brand-name
Compounded only

How we scored AHBARx

Every factor comes from AHBARx's own published pricing, disclosures and oversight, and the six combine into the 32/100 Metabolic-Fit Score on our weighted six-factor framework. Commissions don't change a provider's score.

Postpartum & breastfeeding guidance15/100 · Weak

No postpartum or breastfeeding framing — a generic weight program.

PCOS & hormonal fit20/100 · Weak

Thin on the hormonal picture that drives many mothers' weight.

Clinical oversight & labs30/100 · Weak

Oversight and lab support fall short of the best on our list — the review below says exactly where.

True monthly cost55/100 · Weak

Cost is unpredictable or sits at the premium end.

Ongoing support45/100 · Weak

Support is thin once the prescription ships.

Cancellation fairness40/100 · Weak

Exit terms are the weak point: lock-in, notice periods, or a cancellation you have to chase.

How we checked this review

Six prices, all published before you hand over anything: $249 a month for compounded semaglutide and $349 for tirzepatide, dropping to about $200 and $300 a month if you pay six months up front. The savings figures check out to the dollar. What is missing is the company. No operating entity is named anywhere on the site, and the terms and privacy policy are an unfilled template — pharmacies, labs and medical groups appear as bracketed placeholders, and so does the site's own web address. You can see exactly what it costs and not who you are buying it from.

Pricing

MedicationPricePlan
Compounded semaglutide$2491-month supply, delivered monthlyThe month-to-month rate. Buying ahead lowers it: $649 for three months works out to $216 a month, and $1,199 for six months to $200 a month, though the six-month plan is charged once and ships every three months.
Compounded semaglutide$2006-month supply, one charge of $1,199The cheapest way in, and the least flexible: one payment of $1,199 up front, with medication arriving every three months rather than monthly.
Compounded tirzepatide$3491-month supply, delivered monthlyThe month-to-month rate. Three months is $949, about $316 a month; six months is $1,799, about $300 a month.
Compounded tirzepatide$3006-month supply, one charge of $1,799One payment of $1,799 up front, shipped every three months.

Swipe the table to see plan details →

Many HSA and FSA plans cover GLP-1 telehealth — check yours. These figures are what AHBARx's own site disclosed at last review; this market re-prices often, so confirm the current number at the source.

What we like

  • Six prices published on the product pages before any intake, account or email
  • The advertised three- and six-month savings are exact against its own monthly rate
  • Each plan states its own delivery cadence rather than leaving it to be assumed
  • States plainly that compounded medications are not reviewed or approved by the FDA

The caveats

  • No operating entity is named anywhere on the public site — no LLC, no corporation, no parent
  • The terms and privacy policy are an unfilled template: pharmacies, labs and medical groups are literal bracketed placeholders
  • The site's own web address is still a bracketed placeholder in both legal documents
  • The footer claims LegitScript certification but no certification record could be retrieved
  • Compounded only — no FDA-approved Wegovy, Ozempic, Zepbound or Mounjaro
  • Nothing on the site addresses pregnancy, breastfeeding or postpartum timing

A real monthly option sits beside prepaid plans

AhbaRx lists compounded semaglutide at $249 for one month, $649 for three months, or $1,199 for six months. The longer packages average about $216.33 and $199.83 per month respectively. Those averages help explain the discount, but they are not monthly installments. The six-month option requires one upfront payment. Someone seeking a smaller initial commitment should compare the $249 single-month offer with another seller's single-month price rather than substituting the six-month average.

Tirzepatide costs $349 for one month, $949 for three months, or $1,799 for six months. The longer-package averages are about $316.33 and $299.83 per month. Again, the package purchase is the financial commitment. Ask whether the quoted amount applies to your prescribed dose, what happens if treatment changes, and what the next purchase would cost. A published package discount does not establish a lifetime rate or guarantee that every patient will use the entire purchased period.

Payment and shipment do not happen together

For the six-month offer, AhbaRx describes medication shipments every three months rather than one shipment containing everything at the outset. That distinction matters when asking how future supplies are released and what happens if a prescription needs to change between shipments. Paying upfront does not itself explain the amount sent in each container or the instructions for using it. Request the actual supply schedule, packaging, and clinician review process before committing to the longer plan.

The pharmacy should identify the medication's ingredients, concentration, storage requirements, and usable period. Do not infer permission to keep using a vial for the whole prepaid period from the package length. Compounded semaglutide and tirzepatide are not FDA approved and should not be treated as interchangeable with an approved brand merely because the ingredient name is familiar. The clinician needs to explain the prescription, and the pharmacy needs to provide instructions for the specific product dispensed.

AhbaRx's public legal material contains template-style placeholders for pharmacies, laboratories, medical groups, and site details rather than fully identifying those parties. The legal documents do not clearly name the operating entity. That does not prove the care is unlawful, but it leaves basic accountability questions unanswered. Ask for the seller's legal name, the medical group responsible for treatment, the assigned clinician, and the actual dispensing pharmacy before sharing sensitive information or paying.

The footer includes a LegitScript claim. A claim or displayed badge does not independently verify current certification or establish clinical quality. Likewise, broad nationwide marketing should be confirmed for your residence and proposed prescription rather than accepted as a complete licensing map. Written identification and state eligibility are especially important when a patient is paying for several months before receiving all the medication described in the offer.

Decide how much flexibility you need

AhbaRx sells other wellness products, including NAD-related offerings, sermorelin, and glutathione. Their presence does not establish that they are necessary additions to a GLP-1 prescription or that the service has specialist maternal credentials. If pregnancy planning, breastfeeding, or postpartum circumstances affect treatment, discuss them directly with the clinician. Keep any additional product recommendation and its cost separate from the medication plan you originally intended to compare.

The single-month option provides a more limited financial commitment, while the longer packages trade a larger upfront payment for a lower arithmetic average. Before choosing the latter, obtain the refund rules, cancellation conditions, shipment schedule, and process for changing treatment. A discount has less practical value if the terms do not fit your need for flexibility. Once the business and medical identities are clear, compare those actual commitments alongside the price instead of judging the service on the six-month average alone.

The bottom line for mothers

Best for: Someone comparing published monthly rates who is willing to ask, in writing, which company and which pharmacy are behind the brand before entering a card.

Alternatives to AHBARx

These are partners — we may be paid if you sign up through these links. The full list has every provider we cover, partner or not.

  • CoreAge RxFeatured partner

    CoreAge's officially linked public offer advertises compounded semaglutide at $79/month and tirzepatide at $129/month across doses, with care and overnight shipping included. It describes one-time purchases without a required subscription. Main navigation still shows semaglutide from $99; confirm your prescription quantity and total, and read the refund limits before paying.

    Visit CoreAge Rx
  • Unusually open about its clinicians and pharmacies — a named CMO, roughly forty-five named physicians, three named compounding pharmacies — and unusually loose about its advertising, having dropped 'comparable to FDA-approved semaglutide' claims only after the National Advertising Division referred it to the FTC.

    Visit Willow
  • FDA warning letter #728279 (June 2026), which names Eden's website — read that first. Then read the price twice: the advertised $99 is medication alone, with a required $99-a-month membership on top.

    Visit Eden

Providers like AHBARx

Keep comparing AHBARx

AHBARx, answered

Who operates AHBARx?
The site does not say. Its terms and privacy policy refer only to "AHBARx and/or its subsidiaries and affiliates" — no LLC, no corporation, no parent named. There is a Newport Beach mailing address, an email and a phone number, and that is the whole of it. Most sellers on this list name an operating company in their terms.
Why does it matter that the terms are a template?
Because the blanks are the parts that would tell you who handles your prescription. The documents leave literal placeholders where the compounding pharmacies, laboratories and medical groups should be listed, and the site's own web address is still sitting in brackets. Whoever published them never filled them in, which means the disclosures a customer would rely on do not actually disclose anything.
Is the six-month plan really cheaper?
Yes, and the arithmetic is honest. Six months of semaglutide is $1,199 against $1,494 at the monthly rate, so the advertised $295 saving is exact. The trade is flexibility: it is one charge up front rather than a monthly bill, and the medication arrives every three months instead of every month.

Pricing, states and verification reflect AHBARx's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.

← Back to all providers